General Information of the Compound
| Compound ID |
CP0437829
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-(N-((1r,4r)-4-tert-butylcyclohexyl)-4-(trifluoromethoxy)benzamido)-N-(2H-tetrazol-5-yl)-2,3-dihydro-1H-indene-5-carboxamide
Show/Hide
|
||||||||||||||||||
| Formula |
C29H33F3N6O3
|
||||||||||||||||||
| Molecular Weight |
570.616
|
||||||||||||||||||
| Canonical SMILES |
CC(C)(C)[C@H]1CC[C@@H](CC1)N(C1CCc2cc(ccc12)C(=O)Nc1nnn[nH]1)C(=O)c1ccc(OC(F)(F)F)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C29H33F3N6O3/c1-28(2,3)20-8-10-21(11-9-20)38(26(40)17-4-12-22(13-5-17)41-29(30,31)32)24-15-7-18-16-19(6-14-23(18)24)25(39)33-27-34-36-37-35-27/h4-6,12-14,16,20-21,24H,7-11,15H2,1-3H3,(H2,33,34,35,36,37,39)/t20-,21-,24?
Show/Hide
|
||||||||||||||||||
| InChIKey |
MTBJTQZAQADZQL-JDVJWJCPSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02242, Gastric inhibitory polypeptide receptor
Protein ID: PT01473, Glucagon receptor